Literature DB >> 26892070

Intra-uterine insemination for unexplained subfertility.

Susanne M Veltman-Verhulst1, Edward Hughes, Reuben Olugbenga Ayeleke, Ben J Cohlen.   

Abstract

BACKGROUND: Intra-uterine insemination (IUI) is a widely used fertility treatment for couples with unexplained subfertility. Although IUI is less invasive and less expensive thAppendixan in vitro fertilisation (IVF), the safety of IUI in combination with ovarian hyperstimulation (OH) is debated. The main concern about IUI treatment with OH is the increase in multiple pregnancy rate. This is an update of a Cochrane review (Veltman-Verhulst 2012) originally published in 2006 and updated in 2012.
OBJECTIVES: To determine whether, for couples with unexplained subfertility, IUI improves the live birth rate compared with timed intercourse (TI), or expectant management, both with and without ovarian hyperstimulation (OH). SEARCH
METHODS: We searched the Cochrane Gynaecology and Fertility (formerly Cochrane Menstrual Disorders and Subfertility Group) Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, inception to Issue 11, 2015), Ovid MEDLINE, Ovid EMBASE, PsycINFO and trial registers, all from inception to December 2015 and reference lists of articles. Authors of identified studies were contacted for missing or unpublished data. The evidence is current to December 2015. SELECTION CRITERIA: Truly randomised controlled trial (RCT) comparisons of IUI versus TI, in natural or stimulated cycles. Only couples with unexplained subfertility were included. DATA COLLECTION AND ANALYSIS: Two review authors independently performed study selection, quality assessment and data extraction. We extracted outcomes, and pooled data and, where possible, we carried out subgroup and sensitivity analyses. MAIN
RESULTS: We included 14 trials including 1867 women. IUI versus TI or expectant management both in natural cycleLive birth rate (all cycles)There was no evidence of a difference in cumulative live births between the two groups (Odds Ratio (OR) 1.60, 95% confidence interval (CI) 0.92 to 2.78; 1 RCT; n = 334; moderate quality evidence). The evidence suggested that if the chance of a live birth in TI was assumed to be 16%, that of IUI would be between 15% and 34%.Multiple pregnancy rateThere was no evidence of a difference in multiple pregnancy rate between the two treatment groups (OR 0.50, 95% CI 0.04 to 5.53; 1 RCT; n = 334; moderate quality evidence). IUI versus TI or expectant management both in stimulated cycleLive birth rate (all cycles)There was no evidence of a difference between the two treatment groups (OR 1.59, 95% CI 0.88 to 2.88; 2 RCTs; n = 208; I(2) = 72%; moderate quality evidence). The evidence suggested that if the chance of achieving a live birth in TI was assumed to be 26%, the chance of a live birth with IUI would be between 23% and 50%.Multiple pregnancy rateThere was no evidence of a difference in multiple pregnancy rates between the two treatment groups (OR 1.46, 95% CI 0.55 to 3.87; 4 RCTs, n = 316; I(2) = 0%; low quality evidence). IUI in a natural cycle versus IUI in a stimulated cycle Live birth rate (all cycles)An increase in live birth rate was found for women who were treated with IUI in a stimulated cycle compared with those who underwent IUI in natural cycle (OR 0.48, 95% CI 0.29 to 0.82; 4 RCTs, n = 396; I(2) = 0%; moderate quality evidence). The evidence suggested that if the chance of a live birth in IUI in a stimulated cycle was assumed to be 25%, the chance of a live birth in IUI in a natural cycle would be between 9% and 21%.Multiple pregnancy rateThere was no evidence of a difference in multiple pregnancy rate between the two treatment groups (OR 0.33, 95% CI 0.01 to 8.70; 2 RCTs; n = 65; low quality evidence). IUI in a stimulated cycle versus TI or expectant management in a natural cycleLive birth rate (all cycles)There was no evidence of a difference in live birth rate between the two treatment groups (OR 0.82, 95% CI 0.45 to 1.49; 1 RCT; n = 253; moderate quality evidence). The evidence suggested that if the chance of a live birth in TI or expectant management in a natural cycle was assumed to be 24%, the chance of a live birth in IUI in a stimulated cycle would be between 12% and 32%.Multiple pregnancy rateThere was no evidence of a difference in multiple pregnancy rate between the two treatment groups (OR 2.00, 95% CI 0.18 to 22.34; 2 RCTs; n = 304; moderate quality evidence). IUI in natural cycle versus TI or expectant management in stimulated cycle Live birth rate (all cycles)There was evidence of an increase in live births for IUI (OR 1.95, 95% CI 1.10 to 3.44; 1 RCT, n = 342; moderate quality evidence). The evidence suggested that if the chance of a live birth in TI in a stimulated cycle was assumed to be 13%, the chance of a live birth in IUI in a natural cycle would be between 14% and 34%.Multiple pregnancy rateThere was no evidence of a difference in multiple pregnancy rate between the groups (OR 1.05, 95% CI 0.07 to 16.90; 1 RCT; n = 342; moderate quality evidence).The quality of the evidence was assessed using GRADE methods. Quality ranged from low to moderate, the main limitation being imprecision in the findings for both live birth and multiple pregnancy.. AUTHORS'
CONCLUSIONS: This systematic review did not find conclusive evidence of a difference in live birth or multiple pregnancy in most of the comparisons for couples with unexplained subfertility treated with intra-uterine insemination (IUI) when compared with timed intercourse (TI), both with and without ovarian hyperstimulation (OH). There were insufficient studies to allow for pooling of data on the important outcome measures for each of the comparisons.

Entities:  

Mesh:

Year:  2016        PMID: 26892070     DOI: 10.1002/14651858.CD001838.pub5

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  11 in total

Review 1.  A New Dawn for Intrauterine Insemination: Efficient and Prudent Practice will Benefit Patients, the Fertility Industry and the Healthcare Bodies.

Authors:  Gulam Bahadur; Roy Homburg; Ansam Al-Habib
Journal:  J Obstet Gynaecol India       Date:  2016-08-22

2.  Interventions for unexplained infertility: a systematic review and network meta-analysis.

Authors:  Rui Wang; Nora A Danhof; Raissa I Tjon-Kon-Fat; Marinus Jc Eijkemans; Patrick Mm Bossuyt; Monique H Mochtar; Fulco van der Veen; Siladitya Bhattacharya; Ben Willem J Mol; Madelon van Wely
Journal:  Cochrane Database Syst Rev       Date:  2019-09-05

3.  Intra-uterine insemination for unexplained subfertility.

Authors:  Reuben Olugbenga Ayeleke; Joyce Danielle Asseler; Ben J Cohlen; Susanne M Veltman-Verhulst
Journal:  Cochrane Database Syst Rev       Date:  2020-03-03

4.  The SUPER study: protocol for a randomised controlled trial comparing follicle-stimulating hormone and clomiphene citrate for ovarian stimulation in intrauterine insemination.

Authors:  N A Danhof; M van Wely; C A M Koks; J Gianotten; J P de Bruin; B J Cohlen; D P van der Ham; N F Klijn; M H A van Hooff; F J M Broekmans; K Fleischer; C A H Janssen; J M Rijn van Weert; J van Disseldorp; M Twisk; M Traas; M F G Verberg; M J Pelinck; J Visser; D A M Perquin; D E S Boks; H R Verhoeve; C F van Heteren; B W J Mol; S Repping; F van der Veen; M H Mochtar
Journal:  BMJ Open       Date:  2017-05-25       Impact factor: 2.692

5.  An Intrauterine Insemination Audit at Tertiary Care Hospital: A 4½ Years' Retrospective Analysis of 800 Intrauterine Insemination Cycles.

Authors:  Leena Wadhwa; Ashish Fauzdar; Sanjana Narula Wadhwa
Journal:  J Hum Reprod Sci       Date:  2018 Jul-Sep

6.  Use of clomiphene citrate alone, urinary follicle-stimulating hormone alone, or both combined sequentially in patients with unexplained subfertility undergoing intrauterine insemination: A randomized trial.

Authors:  Reyhan Ayaz; Mehmet Reşit Aşoglu; Selçuk Ayas
Journal:  Turk J Obstet Gynecol       Date:  2019-01-09

7.  The effect of a natural vaginal product based on honey on the success of intrauterine insemination (IUI) in infertility treatment.

Authors:  Maryam Kavousi; Nayereh Khadem Ghaebi; Mona Najaf Najafi; Roshanak Mokaberinejad; Zohre Feyzabadi; Roshanak Salari
Journal:  Avicenna J Phytomed       Date:  2019 Jul-Aug

8.  Effect of HCG-Triggered Ovulation on Pregnancy Outcomes in Intrauterine Insemination: An Analysis of 5,610 First IUI Natural Cycles With Donor Sperm in China.

Authors:  Ji-Peng Wan; Zhen-Jing Wang; Yan Sheng; Wei Chen; Qing-Qing Guo; Jin Xu; Hua-Rui Fan; Mei Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-07       Impact factor: 5.555

Review 9.  Growing body of evidence supports intrauterine insemination as first line treatment and rejects unfounded concerns about its efficacy, risks and cost effectiveness.

Authors:  Gulam Bahadur; Roy Homburg
Journal:  JBRA Assist Reprod       Date:  2019-01-31

10.  Clomiphene Citrate versus Recombinant FSH in intrauterine insemination cycles with mono- or bi-follicular development.

Authors:  Vehbi Yavuz Tokgoz; Yavuz Emre Sukur; Batuhan Ozmen; Murat Sonmezer; Bulent Berker; Rusen Aytac; Cem Somer Atabekoglu
Journal:  JBRA Assist Reprod       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.